IFF price target lowered to $100 from $106 at Morgan Stanley

Morgan Stanley analyst Lisa De Neve lowered the firm’s price target on IFF (IFF) to $100 from $106 and keeps an Overweight rating on the shares. While the firm’s new base case accounts for slower order books, it considers ingredients as better placed to weather a potentially softer macro backdrop across chemicals relative to industrial chemicals and perhaps to some consumer names, the analyst tells investors in a note on the group.